Robotic Rehabilitation Treatment of Stroke Patients

Stroke, Acute Clinical Trial

Official title:

Robotic Rehabilitation Treatment of Stroke Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05300867
• Other study ID #: IKEB2021/10
• Status: Completed
• Phase: N/A
• Start date: April 1, 2022
• Est. completion date: November 1, 2022

Study information

• Verified date: August 2023
• Source: Somogy Megyei Kaposi Mór Teaching Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Storke results in severe deterioration in quality of life and exercise. Severe disorders need to be treated as soon as possible and they need to be rehabilitated quickly in order for motor functions to develop properly. In the acute / subacute phase, patients are given robotic treatment. In addition to the study of mtoros functions, the study of gait and codination is the primary result. Patients treated with soft exoskeleton receive 15 treatments and movement testing is performed continuously. Members of the control group receive standard rehabilitation therapy. After 3 weeks, both groups will participate in a control study and then in a repeat control study at week 6. Our main goal is to compare the results and determine the efficiency of the robotic device.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2
• Est. completion date: November 1, 2022
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 55 Years to 80 Years

Eligibility

Inclusion Criteria:

post stroke 6MWT : 120> minimum after stroke 3 days Exclusion Criteria: Sever heart problem sever demeanor alcoholism drug problems

Related Conditions & MeSH terms

• Ischemic Stroke
• Stroke
• Stroke, Acute
• Stroke, Ischemic

Intervention

Other:
• Neurorehabilitation
Neurorehabilitation with soft exsoskeleton robotic 3-week-long
• Physiotherapy
Physiotherapy 3-week-long

Locations

Country	Name	City	State
Hungary	Dr. Tollár József	Kaposvár	Somogy

Sponsors (1)

Lead Sponsor	Collaborator
Somogy Megyei Kaposi Mór Teaching Hospital

Country where clinical trial is conducted

Hungary, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualiti of life measured by Barthel index	quetionnaire	3 weeks
Primary	gait/functional test	6 minute walk test (m)	3 weeks
Primary	gait/functional test	10 m walk test (m/s)	3 weeks
Primary	balance test	Berg balance test	3 weeks
Primary	postural control test	posturography	3 weeks

External Links

•   Related Info